Accueil / Formation Recherche / Publications / Publications Angoiedèmes à kinines

Publications Angoiedèmes à kinines

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey.

Hereditary angioedema, emergency management of attacks by a call center.

Diagnostic biologique des angioedèmes bradykiniques : les recommandations du CREAK.

Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey.

Bradykinin mechanism is the main responsible for death by isolated asphyxiating angioedema in France.

Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings

Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.

Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: Three additional French families

Hereditary angioedema: Clinical presentation and socioeconomic cost of 200 French patients.

Repeated attacks of type III hereditary angioedema with factor XII mutation during pregnancy


Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.

Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.

Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: Three additional French families. 

Hereditary Angioedema, Clinical Presentation and Socio-Economic Cost of 200 French Patients. 

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.


Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight : findings from the Icatibant Outcome Survey, a cohort observational study. Caballero T et al. Clin Transl Allergy. 2018 Mar 23.
 
Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial. Javaud N et al. Ann Emerg Med. 2018 Mar.
 
Icatibant for ACE-inhibitor angioedema, an opportunity to treat the patients ? Javaud N et al. J Allergy Clin Immunol Pract. 2017 Nov - Dec.

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey. Aberer W et al. Allergy Asthma Clin Immunol. 2017 Jul 5;13:3.

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. Caballero T et al. J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1214-1222.

Normal PAI-2 level in French FXII-HAE patients. Marlu R et al. J Allergy Clin Immunol. 2017 May;139(5):1719-1720.

Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort. Bouillet L et al. Eur J Dermatol. 2017 Apr 1;27(2):155-159.

ACTUALITÉS

Nouveau cas clinique "Amylose AL"
Testez vos connaissances
Le congrès des Rencontres RARE revient pour sa 6ème édition, les 5 & 6 novembre 2019
Cité des Sciences et de l'Industrie, Paris
Les nouvelles recommandations nationales de prises en charge des aplasies médullaires sont en ligne
Nouveau Protocole National de Diagnostic et de Soins 2019 sur le site de la HAS !
Voir toutes les actualités

AGENDA

Du 11-12-2019 au 13-12-2019 : 80ème congrès de la Société Nationale Française de Médecine Interne et session MaRIH, Limoges


17-01-2020 : Réunion annuelle du centre de référence de l'amylose AL et autres maladies par dépôt d'immunoglobulines monoclonales, Paris


Du 23-01-2020 au 24-01-2020 : Congrès de la Société d'Hématologie et d'Immunologie Pédiatrique, Rouen
Voir tout l'agenda